SunTrust Starts OPTR, ACAD, PCYC, TSRX, FURX, PYBI at Buy, ARQL at Neutral

Article Stock Quotes (6) Comments (0)

An analyst at SunTrust Robinson Humphrey initiated coverage on several Biotech stocks Friday morning:

• Optimer Pharma (Nasdaq: OPTR) with a Buy rating and a $20 price target
  
• ACADIA Pharma (Nasdaq: ACAD) with a Buy rating and a $6 price target
  
• Pharmacyclics (Nasdaq: PCYC) with a Buy rating and a $48 price target
  
• Trius Therapeutics (Nasdaq: TSRX) with a Buy rating and a $13 price target
  
• Furiex Pharma (Nasdaq: FURX) with a Buy rating and a $35 price target
  
• Puma Biotech (OTC: PYBI) with a Buy rating and a $19 price target
  
• ArQule (Nasdaq: ARQL) with a Neutral rating

Check out our Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Topeka Capital Starts Laredo Petroleum (LPI) at Buy, Assets 'Undervalued'
• Credit Suisse Starts New Residential Investment (NRZ) at Outperform
• Jefferies Starts Cempra, Inc. (CEMP) at Buy

Create E-mail Alert Related Categories

New Coverage

Related Entities

SunTrust Robinson Humphrey

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?